Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas : A pooled analysis
Copyright © 2016 IAP and EPC. Published by Elsevier B.V. All rights reserved..
OBJECTIVES: The aim of this study was to examine the outcomes of second pancreatectomy for the treatment of recurrent pancreatic ductal adenocarcinoma (PDAC) in the remnant pancreas.
METHOD: Search of the PubMed database was undertaken to identify relevant English language studies. Pooled individually data were examined for clinical outcomes after second pancreatectomy for recurrent PDAC.
RESULTS: A total of 19 articles involving 55 patients were eligible for inclusion. The median disease-free interval after initial resection was 33 (range 7-143) months. Of the 55 patients reported, 52 (94.5%) patients underwent completion total pancreatectomy in the second operation for recurrences, including 15 patients who developed recurrences more than 5 years after the initial operation. There was no perioperative death. The 1-, 3- and 5-year overall survival rate after the second pancreatectomy was 82.2%, 49.2% and 40.6% respectively.
CONCLUSION: Second pancreatectomy for recurrent PDAC can be performed safely with long-term survival in selected patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. - 16(2016), 6 vom: 15. Nov., Seite 1124-1128 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhou, Yanming [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 04.04.2017 Date Revised 01.12.2017 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.pan.2016.09.015 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM265116015 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM265116015 | ||
003 | DE-627 | ||
005 | 20231224211559.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.pan.2016.09.015 |2 doi | |
028 | 5 | 2 | |a pubmed24n0883.xml |
035 | |a (DE-627)NLM265116015 | ||
035 | |a (NLM)27717684 | ||
035 | |a (PII)S1424-3903(16)31216-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Yanming |e verfasserin |4 aut | |
245 | 1 | 0 | |a Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas |b A pooled analysis |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.04.2017 | ||
500 | |a Date Revised 01.12.2017 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2016 IAP and EPC. Published by Elsevier B.V. All rights reserved. | ||
520 | |a OBJECTIVES: The aim of this study was to examine the outcomes of second pancreatectomy for the treatment of recurrent pancreatic ductal adenocarcinoma (PDAC) in the remnant pancreas | ||
520 | |a METHOD: Search of the PubMed database was undertaken to identify relevant English language studies. Pooled individually data were examined for clinical outcomes after second pancreatectomy for recurrent PDAC | ||
520 | |a RESULTS: A total of 19 articles involving 55 patients were eligible for inclusion. The median disease-free interval after initial resection was 33 (range 7-143) months. Of the 55 patients reported, 52 (94.5%) patients underwent completion total pancreatectomy in the second operation for recurrences, including 15 patients who developed recurrences more than 5 years after the initial operation. There was no perioperative death. The 1-, 3- and 5-year overall survival rate after the second pancreatectomy was 82.2%, 49.2% and 40.6% respectively | ||
520 | |a CONCLUSION: Second pancreatectomy for recurrent PDAC can be performed safely with long-term survival in selected patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Review | |
650 | 4 | |a Pancreatectomy | |
650 | 4 | |a Pancreatic ductal adenocarcinoma | |
650 | 4 | |a Prognosis | |
650 | 4 | |a Recurrence | |
700 | 1 | |a Song, Ailing |e verfasserin |4 aut | |
700 | 1 | |a Wu, Lupeng |e verfasserin |4 aut | |
700 | 1 | |a Si, Xiaoying |e verfasserin |4 aut | |
700 | 1 | |a Li, Yumin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. |d 2001 |g 16(2016), 6 vom: 15. Nov., Seite 1124-1128 |w (DE-627)NLM119887509 |x 1424-3911 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2016 |g number:6 |g day:15 |g month:11 |g pages:1124-1128 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pan.2016.09.015 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2016 |e 6 |b 15 |c 11 |h 1124-1128 |